PRL and breast cancer: To begin to assess the clinical relevance of the newly identified PRL-modulated transcripts, we selected the gene product most strongly upregulated by PRL in the in vivo xenotransplant tumors, PTHrP, for protein expression analysis in clinical breast cancer specimens.